Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
22 April, 2018 08:22 IST
Cipla receives final approval for generic Pulmicort Respules
Source: IRIS | 17 Nov, 2017, 10.16AM
Comments  |  Post Comment

Cipla, a global pharmaceutical company, today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Budesonide Inhalation Suspension, 0.25mg/2mL, 0.5mg/2mL, and 1mg/2mL from the United States Food and Drug Administration (USFDA) to market a generic version of Astrazeneca's Pulmicort Respules.

Cipla's Budesonide Inhalation Suspension, 0.25mg/2mL, 0.5mg/2mL, and 1mg/2mL, are AN-rated generic equivalents of Astrazeneca's Pulmicort Respules® and are indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age. The product is available for shipping immediately.

Pulmicort Respules® and generic equivalents had U.S. sales of approximately USD 825M for the 12-month period ending September 2017, as reported by IMS Health.

Shares of the company gained Rs 11.6, or 1.95%, to trade at Rs 605.20. The total volume of shares traded was 22,486 at the BSE (9.43 a.m., Friday).



Cipla Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Welspun Corp bags contract to supply water pipes in MENA region - 20-Apr-2018 10:17
TVS Motor Company launches TVS XL100 Heavy Duty 'i-Touch Start' - 20-Apr-2018 10:14
Yes Bank receives RBI approval to open overseas offices - 20-Apr-2018 10:07
Glenmark Pharma gets final nod for Clobetasol Propionate solution - 20-Apr-2018 10:03
TCS Q4 earnings grow 5.7% sequentially to Rs 69.04 bn - 20-Apr-2018 10:00
Prism Cement is now Prism Johnson - 19-Apr-2018 15:51
NACL Ind enters into strategic alliance with BioWorks - 19-Apr-2018 15:25
Ramco Systems partners with L3 MAS - 19-Apr-2018 15:21
MCX inks pact with Northern India Textiles Mills' Association - 19-Apr-2018 15:16
BP and Reliance sanction second phase of integrated KG D6 development - 19-Apr-2018 13:45
IndusInd Bank Q4 profit grows 27% to Rs 9.53 bn - 19-Apr-2018 13:40
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer